Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
NCT00177268 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-12-30
Summary
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Conditions
- Cutaneous T-cell Lymphoma
- Sezary Syndrome
- Mycosis Fungoides
- Eczema
- Atopic Dermatitis
Interventions
- OTHER
-
Blood draw, skin biopsy or urine collection
Up to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year.
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Oleg E Akilov, M.D., PhD · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
- Primary Completion
- 2030-01-31
- Completion
- 2032-01-31
Countries
- United States
Study Locations
More Related Trials
-
Effect of Denileukin Diftitox on Immune System in CTCL Patients
NCT00254332 ·Status: COMPLETED
-
Dendritic Cell Vaccination for Patients with Solid Tumors
NCT01291420 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
NCT00611208 ·Status: COMPLETED ·Phase: PHASE2
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854 ·Status: RECRUITING
-
Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution
NCT05728879 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
NCT00965224 ·Status: COMPLETED ·Phase: PHASE2
-
Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides
NCT01645293 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
NCT01686334 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Dendritic Cell Based Therapy of Metastatic Breast Cancer
NCT00197925 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Collection of Data and Samples From Healthy Donors for Use in Translational Research
NCT00090662 ·Status: RECRUITING
-
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03735589 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
NCT00683670 ·Status: COMPLETED ·Phase: PHASE1
-
Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission
NCT01096602 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
NCT01875653 ·Status: TERMINATED ·Phase: PHASE3
-
Immunization Against Tumor Cells in Sezary Syndrome
NCT00099593 ·Status: COMPLETED ·Phase: PHASE2
-
DC Vaccination in CML
NCT02543749 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)
NCT01146262 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation
NCT00405327 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
NCT01239875 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dendritic Cell Based Therapy of Malignant Melanoma
NCT00197912 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dendritic Cell Vaccination in Patients With Advanced Melanoma
NCT03092453 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally
NCT00083538 ·Status: COMPLETED ·Phase: PHASE2
-
Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer
NCT05539365 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
NCT04815356 ·Status: RECRUITING ·Phase: PHASE1